KROS vs SPCE · rev $32.0K vs rev $361.0K
Keros Therapeutics Inc (KROS) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
KROS currently screens at market cap $208.8M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the KROS and SPCE stock pages for the full models.
Not investment advice.